As a consequence of demand, NanoVibronix’s (NASDAQ:NAOV) underwriter has agreed to extend the dimensions of the previous public offering ($1.5M) and buy on a agency dedication foundation 1,794,783 frequent shares at $1.00/share, for anticipated gross proceeds of ~$1.8M.
Underwriter’s over-allotment is a further 269,217 shares.
Internet proceeds will probably be used for working capital and different common company functions.
H.C. Wainwright & Co. is performing as the only real book-running supervisor.
Cut-off date is September 25.
The shares rocketed 103% through the common session, following the information of FDA authorization of UroShield.
Yesterday’s shut was $1.20. Shares down 13% after-hours.